Skip to content

Clinical trials

Recruiting Phase 2 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Recruiting Country / region: Netherlands Clear all

182 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20172
20181
20195
20206
202114
20229
202318
202430
202555
202640

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting182

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Netherlands Cancer Institute13
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)11
University Medical Center Groningen10
Merck Sharp & Dohme LLC8
Novartis Pharmaceuticals8
Erasmus Medical Center7
AstraZeneca5
Eli Lilly and Company4
Leiden University Medical Center4
Maastricht University Medical Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms8
Carcinoma, Non-Small-Cell Lung8
Neoplasms7
Crohn Disease5
Urinary Bladder Neoplasms5
Colitis, Ulcerative4
Colorectal Neoplasms4
Esophageal Neoplasms4
Melanoma4
Multiple Myeloma4

Trials

Showing 1 to 25 of 182. Each trial links to its page on Pharma Observatory.

82 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.